How to Buy Dyne Therapeutics Stock
Dyne Therapeutics Inc
Dyne Therapeutics, Inc. , a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States.
Dyne Therapeutics stock last closed at $24.73, up 4.37% from the previous day, and has increased 137.1% in one year. It has overperformed other stocks in the Biotechnology industry by 1.59 percentage points. Dyne Therapeutics stock is currently +286.41% from its 52-week low of $6.40, and -18.3% from its 52-week high of $30.27.
At the moment, there are 81.96M shares of DYN outstanding. The market value of DYN is $2.03B. In the past 24 hours, 616,906 DYN shares were traded.
How to Buy Dyne Therapeutics Stock
Wondering how to invest in Dyne Therapeutics stock? Here's how.
- Decide where to buy Dyne Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Dyne Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Choose your payment method and add your information.
- Analyze Dyne Therapeutics stock: The Dyne Therapeutics ticker symbol is DYN. Is Dyne Therapeutics stock a good investment? Should you buy shares of DYN? How do DYN's underlying business fundamentals look? Do top analysts think Dyne Therapeutics is a good buy? Why has DYN's stock price moved recently? (Hint: Our stock research tools can help you decide if DYN is a good stock to buy).
- Make your DYN purchase: Decide if you will purchase DYN shares at the current market price or use a limit order to purchase DYN stock at a given price.
- Get the latest news on your investment in DYN: Create a watchlist to key updates about your new investment in Dyne Therapeutics shares.
Step 1: Decide where to buy Dyne Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy DYN stock.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Energy, New York to London — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you are able to buy DYN stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on app for stock, your next step is to transfer the money for your investment:
Watch the video below for more details transferring funds into your new brokerage account.
Step 4: Analyze Dyne Therapeutics stock
Once you have identified the best place to buy Dyne Therapeutics stock, it's critical to research their stock prior to investing, so you can understand the risk as well as the upside.
Dyne Therapeutics shares quick numbers
Dyne Therapeutics Fundamentals
WallStreetZen was created to help everyday investors do better fundamental analysis in less time.
You can see all of the due diligence checks on DYN's stock page.
Is DYN stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge DYN's fair value.
Using relative valuations ratios:
- DYN could be overvalued based on its P/B ratio of 22.2x, relative to Biotechnology industry P/B ratio of 5.85x
You can do additional valuation analysis on DYN's stock here.
DYN Financial Summary
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the DYN balance sheet.
- There are more short-term assets than short-term liabilities on the DYN balance sheet.
- Total DYN debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
- DYN has cash burn of 188887000. It does not have enough cash and short-term investments to cover this.
- DYN has a relatively high debt to equity ratio of 0.81.
- DYN has $125.42M in cash and short term investments. This is not enough to cover its annual cash burn of $188.89M.
Is it a good time to buy DYN stock, according to analysts?
Out of 7 sell side analysts who give forecasts on DYN, the consensus analyst rating on Dyne Therapeutics is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Latest DYN Analyst Upgrades/Downgrades
Edward Tenthoff, a bottom 3% analyst from Piper Sandler maintains DYN with a strong buy rating and raises their DYN price target from $27.00 to $29.00, on Mar 6, 2024.
Steven Seedhouse, a top 11% analyst from Raymond James maintains DYN with a strong buy rating and raises their DYN price target from $27.00 to $56.00, on Jan 4, 2024.
Raymond James's Steven Seedhouse raised their price target on Dyne Therapeutics (NASDAQ: DYN) by 107.4% from $27 to $56 on 2024/01/04. The analyst maintained their Strong Buy rating on the stock.
Seedhouse said that the catalysts for their price target hike were "Dyne Therapeutics's 2024/01/03 announcement of initial clinical data from the ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 and from the DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping."
DYNE-101 is "clearly active" and DYNE-251 also looks active, the analyst detailed, arguing that the data "provides clear and convincing validation of Dyne's FORCE™ platform for developing targeted therapeutics for rare muscle diseases."
You can dig deeper into what analysts are projecting on the Dyne Therapeutics stock forecast page.
DYN Trading Indicators
Who is buying/selling DYN?
Over the past 12 months, insiders at DYN have sold more shares than they have bought.
Wildon Farwell, Chief Medical Officer of DYN, was the latest DYN insider to sell. They sold $26,347.40 worth of DYN shares on Mar 12, 2024.
Dig into more about who owns DYN shares here.
Does DYN provide a stable income stream?
No, Dyne Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about DYN?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your DYN purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you want more help buying stocks on eToro, watch the how to video below:
Step 6: Get the latest news on your investment in DYN
Now that you own some DYN shares, you'll want to keep up with your new investment.
Start a watchlist to track the latest developments regarding your DYN stock.
DYN Feed
How to Buy Stock in Dyne Therapeutics
To reiterate, here are the 6 steps to buy stock in Dyne Therapeutics:
- Decide where to buy Dyne Therapeutics stock
- Open your brokerage account
- Fund your brokerage account
- Analyze Dyne Therapeutics stock
- Make your DYN purchase
- Get the latest news on your investment in DYN
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your new investment in Dyne Therapeutics, add DYN to your watchlist by clicking the button below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.